Personalis, Inc. · 1 day ago
Sr. Accountant 1
Personalis is transforming the active management of cancer through breakthrough personalized testing. We are seeking a Senior Accountant with hands-on experience in accounts receivable, revenue accounting, and general ledger activities to support day-to-day accounting operations and contribute to month-end close and audit support.
BiotechnologyGeneticsHealth CareHealth Diagnostics
Responsibilities
Perform accounts receivable functions, including billing, cash application, and collections
Assist with revenue recognition activities in accordance with GAAP
Maintain revenue schedules, deferred revenue, and contract liability reconciliations
Perform GL close, including journal entry preparation, accounts reconciliations, and fluctuation analysis
Assist with internal and external audit requests
Participate in process improvement initiatives
Support ad hoc accounting analysis and special projects
Coordinate with internal teams and external tax advisors to maintain tax-related schedules, reconciliations, and supporting documentation
Prepare and reconcile general ledger accounts used for tax reporting, ensuring accuracy and completeness
Support tax-related audit requests, including documentation for income, sales/use, and payroll taxes
Assist with tracking tax payments, notices, and correspondence
Qualification
Required
Bachelor's degree in Accounting or related field
5–7 years of accounting experience, with exposure to AR and revenue
Strong understanding of GAAP is required
Advanced Excel and ERP experience, knowledge of QAD a plus
Strong organizational skills, attention to detail and highly motivated
Self-starter with strong written and verbal communication skills
Ability to meet deadline consistently and work well under pressure
Team player with “can do” attitude
Preferred
Tax exposure preferred
Benefits
Medical
Dental
Vision
401(k) match
ESPP
Tuition reimbursement
Sick/vacation time
Commuter benefits/ EV charging stations
Onsite gym
Wellness benefits
Company
Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing.
Funding
Current Stage
Public CompanyTotal Funding
$311.25MKey Investors
MerckTempusLightspeed Venture Partners
2024-12-19Post Ipo Equity· $50M
2024-08-16Post Ipo Equity· $36.15M
2021-01-27Post Ipo Equity· $150.1M
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase